Hôpital Saint-Louis is a hospital in Paris, France. It was built in 1611 by architect Claude Vellefaux at the request of Henry IV of France.

During the past decade, Hôpital Saint Louis - Radiotherapy Departement conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital Saint Louis - Radiotherapy Departement" are "Prostate Cancer" (2 trials). Many other conditions were trialed in "Hôpital Saint Louis - Radiotherapy Departement" in a lesser frequency.

Most popular intervention types in "Hôpital Saint Louis - Radiotherapy Departement" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (2 trials), "Bicalutamide" (1 trials) and "Goserelin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Saint Louis - Radiotherapy Departement" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Saint Louis - Radiotherapy Departement". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hôpital Saint Louis - Radiotherapy Departement, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Saint Louis - Radiotherapy Departement, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".